Last Update21 Oct 25Fair value Decreased 1.16%
The analyst price target for Philip Morris International has been revised slightly downward from $190.20 to $188.00, as analysts cite moderating profit margin and revenue growth expectations. Analysts also note that recent share price weakness may present a buying opportunity.
Analyst Commentary
Analysts continue to weigh both the positive catalysts and lingering concerns for Philip Morris International following its recent earnings update and the subsequent downturn in share price.
Bullish Takeaways
- Bullish analysts view the share price pullback as an opportunity and believe the recent decline presents an attractive entry point for long-term investors.
- There is continued optimism around the better-than-expected growth in Q3 organic sales, along with improved profit margins and earnings per share.
- Growth trends suggest effective execution on strategic initiatives, supporting the valuation case even amid internal adjustments.
- The current market reaction is seen by some professionals as exaggerated and not reflective of the company's overall fundamentals and future prospects.
Bearish Takeaways
- Bearish analysts remain concerned about the guidance cut for operating profit, which introduces uncertainty over near-term earnings momentum.
- A more cautious view takes into account the weaker operating profit outlook for the fourth quarter compared to previous expectations.
- Ongoing dynamics related to ZYN in the U.S. market are seen as a potential risk to both U.S. performance and overall growth trajectories.
What's in the News
- Philip Morris International increased its regular quarterly dividend by 8.9 percent to $1.47 per share, raising the annualized dividend to $5.88 per share (Company Announcement).
- The company provided earnings guidance for full year 2025, expecting diluted EPS of $7.39 to $7.49, organic net revenue growth of 6 to 8 percent, and organic operating income growth of 10 to 11.5 percent. This guidance includes the impact of higher U.S. investments (Company Guidance).
- Philip Morris International presented evidence before the Tobacco Products Scientific Advisory Committee regarding the renewal of modified risk tobacco product status for its IQOS heated tobacco devices and consumables in the U.S. market. The company also highlighted growing adoption of smoke-free products worldwide (Company Announcement).
- A $37 million investment has been announced for the Wilson, North Carolina manufacturing facility to expand operations. This will introduce a new production line for TEREA consumables supporting U.S. launch preparations for the IQOS ILUMA system (Company Announcement).
- Pursuing business expansion, Philip Morris International has made recent large-scale investments in U.S. manufacturing, including expansions in Kentucky and Colorado. These expansions are expected to create nearly 1,000 direct jobs (Company Announcement).
Valuation Changes
- Consensus Analyst Price Target has decreased slightly from $190.20 to $188.00, reflecting a modest shift in sentiment.
- Discount Rate has edged down from 7.79 percent to 7.72 percent.
- Revenue Growth estimates have been revised downward marginally, from 8.15 percent to 8.03 percent.
- Net Profit Margin has declined slightly from 29.34 percent to 29.22 percent.
- Future P/E Ratio projections now stand at 25.10x, compared to 25.65x previously.
Key Takeaways
- Accelerating global adoption of smoke-free products and regulatory support are driving strong growth, margin expansion, and lower regulatory risks for the company.
- Investment in digital channels and geographic diversification is boosting consumer engagement, sales effectiveness, and earnings stability across emerging and established markets.
- Declining cigarette demand, regulatory risks, illicit trade, currency volatility, and uncertain smoke-free growth jointly threaten ongoing revenue, market share, and margin stability.
Catalysts
About Philip Morris International- Operates as a tobacco company.
- The accelerating global adoption of smoke-free alternatives-driven by increasing health awareness and regulatory moves away from combustibles-is fueling strong double-digit volume and margin growth in PMI's IQOS, ZYN, and VEEV platforms. This secular shift enables the company to capture new consumer segments, expand its addressable market, and structurally boost net revenues and operating margins over time.
- Growth in disposable incomes and urbanization in emerging markets is supporting robust demand expansion, particularly for PMI's smoke-free offerings, as evidenced by strong volume growth in regions such as Indonesia, Egypt, and the Middle East. Continued geographic diversification and deep market penetration are likely to provide sustained top-line growth and earnings stability.
- PMI's increasing investment in digital channels and direct-to-consumer strategies (e.g., expanded e-commerce and data-driven marketing) is enhancing customer engagement, brand loyalty, and sales effectiveness, supporting both near
- and long-term revenue and operating income growth.
- Scale advantages, a broadening product portfolio, and an expanding IP moat in reduced-risk products are driving margin expansion. Smoke-free margins already surpass combustibles by over 4.5 percentage points, and as the mix continues to shift, this is expected to further increase overall net margins and free cash flow.
- Ongoing regulatory differentiation between smoke-free and combustible products is enabling PMI to benefit from lower relative tax burdens and more favorable policy environments for its core growth portfolio, which should structurally support future earnings growth and reduce regulatory risk relative to competitors less advanced in smoke-free transformation.
Philip Morris International Future Earnings and Revenue Growth
Assumptions
How have these above catalysts been quantified?- Analysts are assuming Philip Morris International's revenue will grow by 8.2% annually over the next 3 years.
- Analysts assume that profit margins will increase from 21.0% today to 29.3% in 3 years time.
- Analysts expect earnings to reach $14.5 billion (and earnings per share of $9.36) by about September 2028, up from $8.2 billion today.
- In order for the above numbers to justify the analysts price target, the company would need to trade at a PE ratio of 25.7x on those 2028 earnings, down from 31.2x today. This future PE is lower than the current PE for the GB Tobacco industry at 33.8x.
- Analysts expect the number of shares outstanding to grow by 0.11% per year for the next 3 years.
- To value all of this in today's terms, we will use a discount rate of 7.79%, as per the Simply Wall St company report.
Philip Morris International Future Earnings Per Share Growth
Risks
What could happen that would invalidate this narrative?- PMI acknowledges the ongoing and potentially accelerating structural decline in combustible cigarette volumes (forecasting a return to a long-term, low single-digit decrease), driven by demographic trends, increased health consciousness, and regulatory headwinds, which may pressure total company revenue and profit as combustibles are still a sizable part of the portfolio.
- The company highlights persistent challenges from illicit tobacco trade and counterfeit products, especially in markets like Indonesia and the EU, undercutting legal sales volumes and eroding legitimate market share, which negatively impacts revenue and operating income.
- Regulatory and tax risks remain, particularly in the EU, where new directives may increase excise taxes on smoke-free or combustible products and where harmonized proposals could lead to greater restrictions or unfavorable changes, thus constraining both volume growth and margins for PMI's key products.
- Currency exposure is highlighted as an ongoing risk, with volatility in major currencies (notably the Swiss franc and local emerging market currencies) impacting reported earnings, cash flow, and potentially net profit margins, as seen in recent quarterly results.
- The company indicates the risk of a possible slowdown in smoke-free product growth (e.g., ZYN and IQOS), due either to restocking discrepancies, slower-than-expected commercial momentum, or competitive pressures, which could impact its ability to offset the secular decline in combustibles and thus threaten long-term revenue growth and operating margin expansion.
Valuation
How have all the factors above been brought together to estimate a fair value?- The analysts have a consensus price target of $190.2 for Philip Morris International based on their expectations of its future earnings growth, profit margins and other risk factors. However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $220.0, and the most bearish reporting a price target of just $153.0.
- In order for you to agree with the analyst's consensus, you'd need to believe that by 2028, revenues will be $49.4 billion, earnings will come to $14.5 billion, and it would be trading on a PE ratio of 25.7x, assuming you use a discount rate of 7.8%.
- Given the current share price of $164.74, the analyst price target of $190.2 is 13.4% higher.
- We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.
How well do narratives help inform your perspective?
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.



